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1. ABSTRACT 
 Parkinson’s disease (PD) is a progressive neurodegenerative disorder that is caused 
partly by the loss of dopamine producing neurons. Dopamine is a conserved neuromodulator 
that aids in the transition between different motor patterns such as swimming, walking, or 
running. This can be observed across many species, including mice, flies, and nematodes. 
The cat-2 mutant strain of the nematode C. elegans has a deletion in the gene encoding 
tyrosine hydroxylase, an enzyme required to synthesize dopamine. Our lab recently 
demonstrated that the cat-2 mutant shares aspects of PD patient dysfunction through its 
inability to transition normally between the “swimming” and “crawling” patterns of motion. 
Currently, PD treatments focus on boosting residual dopamine signaling and are not available 
to maintain motor function once dopamine neurons completely degenerate. To search for 
ways to overcome motor dysfunction in the absence of dopamine, we performed a forward 
genetic screen to identify mutations that suppress poor swim-to-crawl motor transition in cat-
2 mutant. We found several suppressor mutants that improve motor function. Further 
characterization can identify molecular pathways that can be altered to improve motor 
function in the absence of dopamine. This information could provide insight into repair of 
dopamine-deficient neural circuitry in higher level animals and possible approaches to help 
late stage PD patients.  
 
2. INTRODUCTION 
 Many organisms exhibit distinct forms of motion, known as gaits, and switch between 
different gaits in response to various stimuli. For instance, horses display three distinct gaits 
through walking, trotting, and galloping (Alexander, 2003); similarly, humans switch 
between gaits when they transition from walking to running. The molecule dopamine has 
been shown to modulate such gait transition across a wide range of taxa. The unique ability 
of dopamine to regulate locomotion may stem from the large set of dopamine receptors that 
exist across species (Vidal-Gadea & Pierce-Shimomura, 2012). These receptors are divided 
into numerous subtypes. D1-like receptors activate adenylyl cyclase upon dopamine 
stimulation, resulting in increased production of cyclic AMP (cAMP); on the other hand, D2-
like receptors inhibit adenylyl cyclase and decrease levels of cAMP (Neves, 2002). The 
opposing nature of these receptor subtypes allow dopamine signaling to finely regulate 
molecular pathways such as motor pattern transition.  
 The connection between dopamine signaling and motor function can be observed 
through the development of Parkinson’s disease (PD), the second most common 
neurodegenerative disorder in humans (Lebouvier et. al., 2008). Common physical symptoms 
of Parkinson’s include rigidity, shaking, freezing, and inability to begin voluntary 
movements. Physiologically, Parkinson’s disease is characterized by the death of 
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dopaminergic neurons in the substantia nigra, along with other heterogenic populations of 
neurons (Lang & Lozano, 1998). The substantia nigra is a region of the midbrain that is 
responsible for voluntary movements and communicating signals from the basal ganglia to 
other brain structures (Guatteo et. al., 2009). The nigrostriatal pathway between the 
substantia nigra and the dorsal striatum regulates motor function; when nigrostriatal 
dopamine binds to D1 and D2 dopamine receptors in the striata, muscle contractions occur 
and muscle tones change (Guatteo et. al., 2009). When PD has reached advanced stages and 
symptoms manifest, approximately 50% of neurons in the nigrostriatal pathway have 
degenerated. Therefore, the death of dopaminergic neurons in this pathway has severe 
consequences for the motor activity of late stage PD patients. 
 Currently, there are no available treatments that can halt the progression of the disease; 
instead, many existing treatments aim to alleviate symptoms. The most commonly used 
treatment for PD is L-Dopa, a precursor to dopamine. However, treatment with L-Dopa is 
unable to resolve severe motor disabilities and continued usage of the medication can 
exacerbate tremors and dyskinesia (Nadjar, Gerfen, & Bezard, 2009). In some cases of 
advanced PD, deep brain stimulation is used to activate remaining dopaminergic neurons. 
However, this procedure carries the risk of severe surgical and neuropsychiatric side effects 
(Pienaar et. al., 2010). Thus, there is a need for treatment that resolves motor deficits in late-
stage PD.  
 To examine suppression of Parkinsonian motor function in the absence of dopamine, 
we utilized the genetically tractable nematode, Caenorhabditis elegans. These roundworms 
are advantageous as animal models because they have a short life span, reaching adulthood 
within 4 days, are affordable, and produce large amounts of progeny. Furthermore, previous 
experiments have demonstrated that C. elegans can display distinct motor patterns (Vidal-
Gadea et al; 2011). During the crawling pattern, the nematode propagates a slow, deep bend 
down the length of the body, while during the swimming pattern, the bends are shallow and 
rapid. Dopamine is necessary and sufficient to modulate the swim-to-crawl gait transition in 
C. elegans. The cat-2 strain of C. elegans has a 211 bp deletion in the gene for tyrosine 
hydroxylase, the enzyme that produces L-dopa in the dopamine synthesis pathway; thus, this 
strain lacks the ability to produce dopamine (Bettinger et. al., 2004). Disruption of dopamine 
signaling in the cat-2 strain results in defective gait switching, analogous to the motor 
deficits experienced by late stage PD patients (Vidal-Gadea et. al., 2011). Other types of PD 
models rely on the introduction and overexpression of the gene α-synuclein, which leads to 
Lewy body formation and subsequent dopaminergic neuron degeneration (Dauer & 
Przedborski, 2003). While these models are useful for studying ways to prevent neuron 
death, this project seeks to retain dopamine-dependent nervous system function; thus, α-
synuclein based models are not utilized in these experiments.  
 Here, a forward genetic screen was used to introduce random mutations into the cat-2 
model to uncover rare mutants that suppress the Parkinsonian swim-to-crawl motor deficit. 
From this screen, we isolated four viable suppressor mutants that were able to transition 
between gaits equally or more efficiently than the wildtype strain. Through the following 
experiments, we aimed to further characterize these suppressor mutants by analyzing 





3.1: C. elegans husbandry and maintenance 
 C. elegans were grown on nematode growth media (NGM) agar plates seeded with 
OP50 bacteria at 20 degrees Celsius as previously described (Brenner 1974). The N2 strain 
was used as the wild-type. For a list of the strains and allele designations used in this 
experiment, see Figure 1.  
 
Strain Allele Designation Background/Description 
N2 - Wild-type 
cat-2 (JPS651) - PD model 
JPS871 vx26 Suppressor mutant with JPS651 background 
JPS872 vx27 Suppressor mutant with JPS651 background 
JPS873 vx28 Suppressor mutant with JPS651 background 
JPS896 vx29 Suppressor mutant with JPS651 background 
 
Figure 1: C. elegans Strain Characteristics. The N2 and cat-2 strains were obtained from 
the Caenorhabditis Genetics Center. Suppressor mutants from the forward genetic screen 
were assigned strain names using the designated lab prefix (JPS) and were also assigned 
unique allele names.  
 
      3.2: Forward genetic screen 
 The cat-2 mutant strain, which carries the 211 bp deletion for the tyrosine hydroxylase 
gene, was used for forward mutagenesis because the nature of the deletion makes the 
uncovering of revertant mutants from the suppression screen unlikely. A population of the 
cat-2 strain at the L4 stage was incubated in N-methyl-N-nitrosourea (ENU) for four hours. 
After incubation, the worms were rinsed in NGM and allowed to recover for three hours on a 
plate seeded with OP50. 100 of these mutagenized cat-2 individuals, referred to as the P0 
generation, were picked and distributed on 10 different plates. After the P0 individuals 
reached adulthood, they laid eggs for 12 hours (F1 generation) on each of the 10 plates. The 
F1 worms reached adulthood and laid eggs, giving rise to the F2 generation. Lastly, as the F2 
generation reached adulthood, they were screened as a population for swim to crawl 
transition efficiency through a radial dispersion assay.  
 
3.3: Radial Dispersion Assays 
 The swim to crawl efficiency of a strain on a population level was assessed by 
modifying previously used methods of evaluating locomotion (Vidal-Gadea et. al., 2011). 
For this assay, unblemished 6 cm agar plates were selected and prepared by placing a 
solution of diacetyl along the circumference of the plate. Four evenly spaced 2 µL droplets of 
diacetyl were pipetted onto the plate’s perimeter and a watercolor brush was used to spread 
the diacetyl solution around the circumference. The placement of the diacetyl motivates the 
worms to crawl towards the outer edges of the agar.  
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 Populations of worms were tested on either the first or second day of adulthood. 
Approximately 50-100 age matched adult worms from a population were picked and 
transferred from agar plates to an Eppendorf tube containing 1.5 mL of NGM. The worms 
were rinsed twice with NGM to remove any residual OP50 that was transferred along with 
the worms. Then, a Drummond pipette fitted with a 25 µL capillary tube was used to transfer 
the worms from the Eppendorf tube to the prepared agar plate with diacetyl by ejecting a 
small (5-10 µL) puddle of worms suspended in buffer onto the center of the plate.  
 The worms were then transferred to a recording chamber that used darkfield style 
illumination. A USB microscope was used to record the worms transitioning from swimming 
in the puddle to crawling on the plate. The time lapse recording starts just prior to the worms 
beginning to emerge from the puddle and continues for two minutes, capturing the video at a 
rate of 1 frame per 2 seconds.  
 The resulting 2 minute time lapse recording was processed and analyzed with ImageJ 
processing software. The images of the plate were divided into four concentric zones, as 
shown in Figure 2. Manual counts of the number of worms in each zone at the 0, 20, 40, 60, 
80, 100, and 120 second intervals were recorded for each population.  
 
Figure 2: Radial Dispersion Setup and Analysis. An ImageJ macro was created that 
divided each image of the plate into four concentric zones, as shown above. For each of the 
specified time intervals, manual counts of the number of worms were recorded for 
subsequent analysis.  
 
3.4: Treatment with 6-hydroxydopamine 
 To observe the behavior of worm populations under induced dopamine neuron 
degeneration, previous methods utilizing 6-hydroxydopamine (6-OHDA) were modified 
(Nass, Hall, Miller, & Blakely, 2002). As 6-hydroxydopmaine oxidizes quickly and easily, 
the antioxidant ascorbic acid was added to each of the solutions.  
 In preparation for 6-OHDA treatment, an age matched population of worms at the L4 
stage was transferred from an agar plate to an Eppendorf tube and was rinsed three times 
with dH2O to remove residual OP50 bacteria. 250 µL of the L4 worms suspended in dH2O 
was then added to a 250 µL solution of 60 mM 6-OHDA/80 mM ascorbic acid. The resulting 
6 
 
tubes was mixed, resulting in the worms suspended in 500 µL of 30 mM 6-OHDA/40 mM 
ascorbic acid solution. The tube was then gently mixed for 30 minutes at room temperature. 
After the 30 minutes, the worms were rinsed with dH2O and transferred to a seeded agar 
plate for recovery. After 24 hours of recovery, the worm population was tested for swim-to-
crawl efficiency using the radial dispersion assay.  
 
3.5: Exogenous dopamine treatment 
 The behavior of the suppressor mutant strains when treated with exogenous dopamine 
was analyzed by adding slight modifications to the radial dispersion procedure. Worms that 
have reached the first or second day of adulthood were transferred from an agar plate to an 
Eppendorf tube, and were then rinsed with NGM twice. 100 µL of the rinsed worms 
suspended in the NGM buffer was then mixed with 100 µL of a 50 mM dopamine solution, 
leaving the worms immersed in a 25 mM dopamine solution. After the worms soaked in the 
exogenous dopamine for 5 minutes, they were rinsed twice with NGM. A Drummond pipette 
was used to pipette the worms in a 5-10 µL puddle at the center of a plate lined with diacetyl, 
as previously described. The radial dispersion assay is then performed.  
 
3.6: Outcrossing 
 To prepare the suppressor mutant strains for whole genome sequencing, they were 
outcrossed against their parent strain cat-2 to remove any background mutations not related 
to motor deficit suppression.  
 To backcross the suppressor mutants, hermaphrodites from the suppressor mutants were 
crossed against males from the cat-2 strain. These males were generated by incubating cat-2 
hermaphrodites in the L4 stage for 3 hours at 30 degrees Celsius. After this heat shock 
procedure, males were isolated from the F1 generation. 6 cat-2 male worms and 2 
hermaphrodites from the suppressor mutants were placed together on a plate and allowed to 
mate for 24 hours. After this time passed, the hermaphrodites were picked onto a separate 
plate. Once the F1 progeny of these mated hermaphrodites reached the L4 stage, 10 random 
worms were picked and placed onto 10 individual plates (1 worm/plate). Then, when the F2 
progeny of each of these 10 worms reached adulthood, the adult worms were evaluated in a 
radial dispersion assay. The worms that still displayed the most efficient swim-to-crawl 
transitions and suppression of the cat-2 motor deficit were isolated to be used for further 
backcrossing.  
 In order to maximize removal of background mutations, 6 total backcrosses were 
performed for every mutant strain.  
 
4. RESULTS 
4.1: Absence of dopamine impairs swim-to-crawl transition 
 To examine gait transition in C. elegans in the absence of dopamine, we conducted 
radial dispersion assays on the wildtype strain and the cat-2 PD model. While the 120 second 
duration of the assay was a sufficient time interval for approximately half of the worms to 
reach the outer two zones, the majority of cat-2 worms remained in the inner zones at this 
time point. By the end of the assay, a significantly larger proportion of wildtype worms 
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(15.01% ± 13.2) reached the outermost zone, zone 3, when compared to the cat-2 worms  
(2.1% ± 4.4).  
 Qualitative observations of the time lapse recordings showed that while wildtype 
worms reach the outer zones by moving at a steady pace, cat-2 worms tend to freeze and 
reverse in the inner zones of the plate. As cat-2 worms emerge from the puddle and attempt 
to initiate crawling behavior, they exhibit unusual flaccid posture and are not able to 
propagate bends along the length of their body as quickly as wild type worms.  
 Therefore, the results of these experiments confirm that cat-2 displays the expected 
swim-to-crawl motor deficit and that the radial dispersion assay is sufficient to capture motor 
activity.  
 
Figure 3: Radial dispersion of wildtype and cat-2 (PD model) strains. Radial dispersion 
assays were set up as shown in Figure . (A) an illustration of 
 
4.2: Forward genetic screen uncovers mutations that suppress motor deficit 
 After mutagenesis of cat-2 with ENU, progeny were screened for regain of swim-to-
crawl transition. Four suppressor mutants that successfully suppressed the Parkinsonian 
motor phenotype were isolated and assigned strain and allele names as documented in Figure 
1. Multiple radial dispersion assays were performed on each of these suppressor strains to 
evaluate their abilities to switch gaits. As shown in Figure 4 G and H, each suppressor mutant 
population had a higher percentage of worms in outer zones when compared to cat-2. Of 
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particular interest, the vx28 strain showed a significantly larger proportion of worms reaching 
the outermost zone even when compared to the wildtype strain.  
 
Figure 4: Radial dispersion of suppressor mutants from forward genetic screen.  
 
4.3: Improved motor function of suppressor mutants not explained by hyperactivity 
 One potential explanation for the increased efficiency of gait transition in suppressor 
mutants may be locomotor hyperactivity; the worms may simply be crawling faster instead of 
regaining the ability to transition between motor patterns. To test this hypothesis, the worms 
were tested in a radial dispersion assay that did not require a swim to crawl transition; 
instead, the worms were picked to the center of the plate without being placed in a puddle, 
and crawled for 2 minutes. The results of this “dry” radial dispersion assay show no 
significant difference between the proportion of worms able to reach the outermost zone at 





Figure 5: Dry radial dispersion of suppressor mutants.  
 
4.4: Induced dopaminergic neuron degeneration did not significantly impair mutant motor 
function 
 When treated with 6-OHDA, the wildtype strain performed significantly worse on the 
radial dispersion assay, at a level comparable to cat-2. There were no significant differences 
between untreated worms and worms treated with 6-OHDA for any of the four mutant 
strains. However, it is important to note that vx26 trends towards increased performance 
following 6-OHDA treatment, while vx27 trends towards decreased performance. The 
nonsignificant difference between untreated and treated worms may stem from the small 
sample size used in this assay. Additional trials are needed to validate the observed results 
from 6-OHDA exposure.  
 
 
Figure 6: Motor function of suppressor mutants following 6-OHDA treatment. Radial 
dispersion assays were performed on populations of worms exposed to 6-OHDA. (A) 
illustrates the proportion of worms that reached the outermost region, zone 3, at each time 
interval in the 2 minute radial dispersion assay. (B) shows the proportion of worms that 
reached zone 3 at the 2 minute time point for both untreated worms and worms treated with 
6-OHDA. Wild type (N = 6, p < 0.0079), cat-2 untreated (N = 15), vx26 (N = 4, p = 0.0526), 
vx27 (N = 5, p = 0.1214), vx28 (N = 5, p = 0.1062) and vx29 (N = 5, p = 0.3511).     
 
4.5: Exogenous dopamine treatment shows variable effects on mutant strains 
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 As the suppressor mutant strains are able to successfully transition between motor 
patterns in the absence of dopamine, we explored how the presence of dopamine could affect 
their motor activity. As expected, an increased proportion of cat-2 worms were able to reach 
zone 3 following exogenous dopamine treatment. Two strains, vx26 and vx28, showed a 
decreased ability to transition between swimming and crawling after exogenous dopamine 
treatment; moreover, the decrease in the percentage of worms able to reach the outermost 
zone was significant in vx28. vx27 showed a slight increase in gait transition efficiency after 
exogenous dopamine treatment, but the change was nonsignificant. Lastly, the vx29 did not 
show any significant change in motor function after exogenous dopamine treatment.  
 
 
Figure 7: Motor function of suppressor mutants following exposure to exogenous 
dopamine. Radial dispersion assays were performed on populations of worms exposed to 
exogenous dopamine. (A) illustrates the proportion of worms that reached the outermost 
region, zone 3, at each time interval in the 2 minute radial dispersion assay. (B) shows the 
proportion of worms that reached zone 3 at the 2 minute time point for both untreated worms 
and worms treated with exogenous dopamine. 
 
5. DISCUSSION 
 Through the forward genetic screen, four suppressor mutants were successfully isolated 
and exhibited efficient gait transition. The radial dispersion assays performed with each of 
the mutant strains showed that all were able to transition between different gaits better than 
cat-2 worms, with two strains (vx26 and vx28) exhibiting better motor activity than wildtype 
worms (Figure 3). Moreover, the mutant strains performed better than the cat-2 strain only 
when transitioning between swimming and crawling behaviors in a radial dispersion assay. 
When evaluated in a dry dispersion assay where the worms crawl without switching to a 
different gait, the difference in locomotor speed between the mutant strains and the cat-2 
strain was nonsignificant (Figure 4). Therefore, the regain of motor function in the 
suppressor mutants is specific to gait transition and is not a result of general hyperactivity.  
 By evaluating the behavioral responses of these mutants under various assays, we 
aimed to further characterize the mechanism by which they overcame their motor deficit. 
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There are numerous potential pathways that can be altered to help suppress the Parkinsonian 
motor phenotype in the mutant strains. Due to the known link between dopamine and gait 
transition in C. elegans, a reasonable hypothesis is that the mechanism of suppression occurs 
within the dopamine signaling pathway itself. Two types of dopamine receptors in C. elegans 
have been functionally characterized: 1) the D1-like receptor, DOP-1, and 2) the D2-like 
receptors, DOP-2 and DOP-3 (Suo et. al., 2004). These receptors are G-protein coupled 
receptors that have opposing effects on the dopamine signaling pathway upon activation, as 
previously described. DOP-1 knockout mutants are known to exhibit a similar inability to 
transition between gaits as the cat-2 strain (Vidal-Gadea & Pierce-Shimomura, 2012). 
Therefore, mutations that lead to constituently active DOP-1 signaling could overcome the 
cat-2 motor deficit.  
 The behavior of the suppressor mutants when exposed to exogenous dopamine provides 
insight into whether the dopamine signaling pathway is still active in the mutant strains. Wild 
type worms with normal dopamine signaling are known to exhibit paralysis upon exposure to 
higher concentrations of exogenous dopamine (Chase, Pepper, & Koelle, 2004). Thus, if  
DOP-1 signaling is constituently active in the suppressor mutant strains, we expect them to 
exhibit a similar paralysis due to dopamine hypersensitivity. Two strains, vx26 and vx28, 
showed decreased locomotor performance in radial dispersion assays following exposure to 
exogenous dopamine (Figure 7). Given that both strains exhibit efficient gait transition at 
levels equal to or higher than wildtype in regular radial dispersion assay (Figure 4), it is 
likely that they are exhibiting dopamine hypersensitivity due to existing active downstream 
dopamine signaling. It is important to consider that wild-type worms in this experiment did 
not exhibit the expected paralysis behavior. This could be a result of the lower number of 
trials with exogenous dopamine performed on the wildtype worms. Additionally, previous 
experiments exposed the worms to exogenous dopamine for longer time intervals (20 min) 
than was used in this assay (10 min) (Chase, Pepper, & Koelle, 2004). Thus, further 
experiments are needed to validate the observed results from this assay.  
 Moreover, the response of the suppressor mutants to 6-OHDA treatment can help 
determine whether dopamine production is still active in the mutant strains. Because 
dopamine production is already impaired in these suppressor mutants, we hypothesize that 
inducing degeneration of dopaminergic neurons will not have an effect on the gait transition 
in these mutant strains. Among the majority of the suppressor mutants, there was no 
significant difference in motor activity between untreated worms and worms exposed to 6-
OHDA. Thus, the results are mostly consistent with our hypothesis, and the induced 
degeneration of dopamine producing neurons does not appear to impact the strains’ abilities 
to transition between gaits. However, it should be noted that the vx27 strain does trend 
towards decreased motor function after treatment with 6-OHDA. This could suggest that 
some level of dopamine production is still active in this strain and contributes to the 
suppression of the motor deficit.  
 To determine the general characteristics of each mutant strain, the results from the 
procedures can be consolidated and examined as a whole. The vx26 and vx28 strains 
consistently show gait transition efficiency at levels similar to or higher than the wildtype 
strain. Both strains also display dopamine hypersensitivity in the exogenous dopamine assay 
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and appear to be unaffected by 6-OHDA treatment. These results hint that the mechanism of 
suppression for these strains makes the downstream component of DOP-1 signaling 
constituently active. Such mutations may include mutations that prevent GTP hydrolysis or 
mutations that increase the conformational flexibility of the GCPR, allowing signal 
transduction without ligand binding (Stoy & Gurevich, 2015). Additionally, the vx27 strain 
displays increased performance in response to exogenous dopamine. One potential 
explanation for this result is that multiple neuronal pathways aid in regulating gait transition 
within vx27; thus, the addition of exogenous dopamine leads to additive effects of both the 
dopamine signaling pathway and the other method of suppression, resulting in improved 
motor function. Finally, the vx29 strain displays higher motor activity than cat-2 but does not 
exhibit dopamine hypersensitivity in response to exogenous dopamine and is not affected by 
induced dopaminergic neuron degeneration. These results suggest that the mechanism of 
suppression in vx29 may be due to a mutation in a pathway not directly related to dopamine 
signaling.  
 Though dopamine-independent methods of suppression were not fully explored through 
the performed experiments, other pathways not directly related to dopamine signaling could 
cause the observed results. Our group previously demonstrated that the neurotransmitter 
serotonin also plays a role in gait transition; in C. elegans, dopamine appears to initiate 
crawling while serotonin initiates swimming behaviors (Vidal-Gadea et. al., 2011). A 
balanced ratio of dopamine and serotonin is thus needed to maintain effective motor 
transition. In the cat-2 mutant, the deletion of tyrosine hydroxylase and the subsequent lack 
of dopamine production impairs the dopamine-serotonin balance, potentially exacerbating the 
inability to transition between gaits. Then, it is possible that serotonin levels in the suppressor 
mutants have been altered to restore a balance. Further experiments that examine the levels 
of serotonin in these suppressor mutant strains can determine whether the dopamine-
serotonin interaction in these nematodes has been altered to produce the observed motor 
behaviors. It is important to consider that like humans, C. elegans have hundreds of 
neuropeptides that could be contributing to the regulation of motor patterns; thus, it is 
difficult to hypothesize which components can suppress Parkinsonian motor function. 
Therefore, the unbiased approach of the forward genetic screen enables us to better identify 
potential mechanisms of recovery without guessing or estimation.  
 In the future, whole genome sequencing (WGS) of the suppressor mutant strains will be 
performed to identify the individual mutations responsible for the recovery of motor 
function. To prepare the suppressor mutants for sequencing, they must be first outcrossed 
against their parent strain, cat-2, to remove the random background mutations that are 
unrelated to locomotion. Once the strains have been successfully outcrossed to minimize 
background noise, WGS sequencing data will allow us to identify the molecular pathways 
that can be altered to alleviate dopamine deficiency related motor symptoms. Determining 
the location, characteristics, and nature of the suppressor mutations will provide further 
insight into potential mechanisms that overcome the motor deficits characteristic of late stage 
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